Studies

    Phthalates in Hair Products: The Science on Cumulative Risk

    Longitudinal analysis reveals cumulative phthalate exposure from leave-on hair products poses risks to reproductive health and child development.

    May 22, 2026

    Phthalates in Hair Products: The Science on Cumulative Risk
    AI-generated image

    [!answer] Cumulative exposure to phthalates from leave-on hair products is a health concern due to their role as potential endocrine disruptors. These chemicals, absorbed through the scalp, accumulate over time and are associated with risks to reproductive health and child development. Women and children may face greater risks due to higher product use and developmental vulnerability [2][5].

    The gels, sprays, and creams we use to style our hair are designed to stay put for hours, allowing their ingredients a long window for absorption. While a single application poses a negligible risk, the central question for scientists is what happens over a lifetime of daily use, and how these small, repeated exposures add up.

    What are phthalates and why are they used in hair products?

    Phthalates (pronounced THAL-ates) are a family of chemical compounds primarily used to make plastics more flexible and durable. In cosmetics, they serve two main functions. First, they are used as solvents and stabilizers in fragrances to make the scent last longer. Diethyl phthalate (DEP) is the most common one found in personal care products [1]. Second, they can be used in products like hairspray to create a flexible, non-brittle film over the hair.

    These chemicals are not chemically bound to the product, which means they can leach out easily. When a hair gel or serum containing phthalates is applied, the chemicals can be absorbed through the skin of the scalp or inhaled as the product’s scent disperses. Because they are designed for prolonged wear, leave-on products like mousses, anti-frizz serums, and hairsprays represent a significant and sustained source of exposure compared to rinse-off products like shampoos.

    Compounding this, the use of personal care products is widespread and often begins in childhood [5]. This creates a scenario of low-dose, high-frequency exposure that can last for decades, leading to a cumulative "body burden" of these chemicals. The total health impact is therefore not about a single product or a single day, but the accumulation of exposures from multiple sources over a lifetime [6].

    How does cumulative exposure work?

    Cumulative exposure refers to the total amount of a substance an individual is exposed to from all sources over time. For phthalates, this includes not just a single hair product but the combination of all personal care products used, as well as exposure from food packaging, vinyl flooring, and other plastics [6]. Research focuses on how the body processes these chemicals and whether they accumulate faster than they can be eliminated.

    Leave-on hair products are a key piece of this puzzle. Unlike a shampoo that is quickly washed away, a styling cream or finishing spray remains on the hair and scalp for 8, 12, or even 24 hours. During this extended contact time, ingredients can be absorbed into the bloodstream. While the dose from one use is small, daily application over months and years means the body is constantly being topped up with these compounds.

    This continuous, low-level exposure is a central concern in toxicology. The body is effective at metabolizing and excreting some phthalates, but with constant re-exposure, a steady-state level of the chemicals and their metabolites can be maintained in the body. It is this persistent internal dose that researchers believe may interfere with sensitive biological processes, particularly the endocrine system [5].

    [!quote] Emerging evidence highlights how PCP-related exposures are not evenly distributed, but shaped by intersecting forces of gender, race and social inequality. Despite being framed as tools for empowerment and wellness, PCPs may contribute to disproportionate toxic exposures, particularly for women and girls. — [2]

    What are the primary health concerns linked to phthalates?

    The primary health concern surrounding phthalates is their ability to act as endocrine-disrupting chemicals (EDCs). The endocrine system is a network of glands that produce hormones, which regulate nearly every process in the body, from metabolism and growth to reproduction and mood. EDCs can interfere with this system by mimicking, blocking, or otherwise altering the body’s natural hormones [1][5].

    Because hormones operate at very low concentrations, even small disruptions from EDCs can have significant effects, especially during critical windows of development like pregnancy and early childhood [5]. Much of the research has focused on the anti-androgenic effects of some phthalates, meaning they can interfere with male sex hormones. This has led to associations between phthalate exposure and impacts on male reproductive health.

    However, the concerns are broader. Phthalates are linked to a range of health issues, including potential impacts on fertility in both men and women, respiratory health, and neurological development [1]. The Minderoo-Monaco Commission on Plastics and Human Health identified phthalates as hazardous chemicals that pose risks throughout their lifecycle, from production to disposal [6]. The cumulative effect of these exposures is a key area of ongoing scientific investigation.

    Are some people more vulnerable to exposure?

    Yes, the evidence strongly suggests that exposure and risk are not distributed equally across the population. Women, on average, use more personal care products than men, resulting in a higher aggregate exposure to ingredients like phthalates. This "gendered exposure" means that women bear a disproportionate body burden of many cosmetic-related chemicals [2].

    Furthermore, studies show that product use patterns vary by race and ethnicity, with some data suggesting women of color may experience higher exposures due to the types and number of products marketed to and used by them. This raises critical issues of health equity, as the burden of exposure may fall most heavily on specific communities [2].

    Children and developing fetuses are uniquely vulnerable. The endocrine, reproductive, and nervous systems undergo rapid, complex development during gestation, infancy, and puberty. Exposure to EDCs during these sensitive periods can cause permanent changes and increase the risk of adverse health outcomes later in life [5]. For this reason, understanding the potential impacts of phthalates in cosmetics on maternal hormones is crucial for expectant parents.

    Why is it hard to study the long-term effects?

    Studying the long-term health effects of a single chemical like a specific phthalate is incredibly challenging. In the real world, we are exposed to a "cocktail" of many different chemicals from many different sources every day. Isolating the effect of one ingredient from a hair product over a 30-year span is nearly impossible. Most human studies are therefore observational, looking for statistical associations between levels of phthalate metabolites in urine and certain health outcomes. These studies can show correlation, but they cannot prove causation.

    Another challenge is that the phthalate family includes many different chemicals, each with a slightly different toxicological profile. Some, like DBP and DEHP, have been more strongly linked to health concerns and are more heavily regulated, while others, like DEP, are considered to have a weaker effect and are still widely used in cosmetics [1].

    Finally, the concept of cumulative risk itself is complex. Scientists must consider dose, frequency, timing of exposure, and potential synergistic effects where one chemical might amplify the effect of another. These complexities mean that scientific consensus often builds slowly, and regulatory guidance can lag behind emerging concerns. This is why many health advocates and scientists call for a precautionary approach, especially for vulnerable populations.

    [!quote] Thousands of natural or manufactured chemicals were defined as endocrine-disrupting chemicals (EDCs) because they can interfere with hormone activity and the endocrine system. — [5]

    How can I identify and avoid phthalates in hair products?

    Unfortunately, reading a label to avoid phthalates isn't always straightforward. While some products are explicitly labeled "phthalate-free," in most cases, you won't see the word "phthalate" in the ingredient list. This is because phthalates used in fragrance are often considered part of a trade-secret formula and can be legally hidden under the generic terms "fragrance," "parfum," or "aroma."

    To effectively avoid them, you can take a few key steps. First, look for products that are explicitly marketed as "phthalate-free." Second, you can opt for fragrance-free or unscented products, as this eliminates a primary source of phthalates. To learn more about identifying these and other similar ingredients, you can read our guide on how to spot endocrine disruptors on a cosmetics label.

    Choosing products certified under standards like USDA Organic or COSMOS can also help, as these programs restrict the use of phthalates and other synthetic chemicals. While no method is foolproof, these strategies can significantly reduce your cumulative exposure from leave-on hair products and other cosmetics.

    The takeaway

    While no single use of a hair product containing phthalates is cause for alarm, the scientific evidence points toward a valid concern about cumulative, long-term exposure. Given the potential for endocrine disruption, individuals who use leave-on hair products daily—especially children, those planning a family, or anyone wishing to be cautious—may want to choose products explicitly labeled "phthalate-free" or "fragrance-free." Making this small change is a practical, evidence-based step to reduce your body's overall chemical burden.

    Sources

    1. [1] The impact of perfumes and cosmetic products on human health: a narrative review.Alblooshi S.. 2025 · Europe PMC
    2. [2] Gender, self-care and toxic exposures: a narrative review of personal care product use and health equity implications.Prifti E, El-Osta A.. 2025 · Europe PMC
    3. [3] Abstracts for the ISEE Asia and Western Pacific (AWPC) Chapter. 2024 · Europe PMC
    4. [4] ISEE Young Rennes 2024 Abstracts. 2024 · Europe PMC
    5. [5] Endocrine Disrupting Chemicals' Effects in Children: What We Know and What We Need to Learn?Predieri B, Iughetti L, Bernasconi S, Street ME.. 2022 · Europe PMC
    6. [6] The Minderoo-Monaco Commission on Plastics and Human Health.Landrigan PJ, Raps H, Cropper M, Bald C, Brunner M, Canonizado EM, Charles D, Chiles TC, Donohue MJ, Enck J, Fenichel P, Fleming LE, Ferrier-Pages C, Fordham R, Gozt A, Griffin C, Hahn ME, Haryanto B, Hixson R, Ianelli H, James BD, Kumar P, Laborde A, Law KL, Martin K, Mu J, Mulders Y, Mustapha A, Niu J, Pahl S, Park Y, Pedrotti ML, Pitt JA, Ruchirawat M, Seewoo BJ, Spring M, Stegeman JJ, Suk W, Symeonides C, Takada H, Thompson RC, Vicini A, Wang Z, Whitman E, Wirth D, Wolff M, Yousuf AK, Dunlop S.. 2023 · Europe PMC
    7. [7] OpenFDA Cosmetic Adverse Event Report (#1). FDA Adverse Event Reporting System (2023) · OpenFDA
    8. [8] OpenFDA Cosmetic Adverse Event Report (#2). FDA Adverse Event Reporting System (2018) · OpenFDA
    9. [9] OpenFDA Cosmetic Adverse Event Report (#3). FDA Adverse Event Reporting System (2025) · OpenFDA
    10. [10] OpenFDA Cosmetic Adverse Event Report (#4). FDA Adverse Event Reporting System (2024) · OpenFDA

    More to know

    The ElysiNexa letter

    Quiet, evidence-based dispatches on non-toxic cosmetics. One email, every other week.

    Editorial newsletter only — not medical advice. Unsubscribe any time.